Cancer is one of the leading causes of death worldwide, and colorectal cancer is among the most common types. Oxaliplatin manufacturer has become a critical component of cancer treatment, especially for patients with advanced stages of colorectal cancer. It is part of a chemotherapy regimen known as FOLFOX, which combines oxaliplatin with other drugs like 5-fluorouracil (5-FU) and leucovorin. This combination has been shown to improve survival rates in cancer patients and reduce the risk of cancer recurrence. Without oxaliplatin, many cancer treatments would be less effective, highlighting its life-saving role.
top of page
bottom of page